TRxA 2024 Funding Opportunities

Critical Path Institute’s (C-Path) Translational Therapeutics Accelerator (TRxA) is proud to announce its 2024 global Request for Proposals for its Breakthrough Research and Innovation in Drug Development Grants (BRIDGe). These BRIDGe awards are designed to support academic researchers in traversing the drug development valley of death by funding and defining optimal strategies for advancing new, cutting-edge therapeutics from the lab to patients.

Join us on Tuesday, January 30 at 10 a.m. EST to learn more about TRXA and its 2024 funding opportunities. Content will include an overview of the types of projects TRxA funds, eligibility criteria for BRIDGe awards, and details about how to apply before the first submission deadline of March 31st, 2024. The webinar will conclude with a live Q&A.